CLINICAL ROLE -
Ryan Haumschild, PharmD, MS, MBA leads a panel of medical experts in a discussion surrounding the significance of adult pneumococcal vaccination.
EP. 1: Signs and Symptoms of Pneumococcal Infections
Medical experts provide an overview of the signs and symptoms of pneumococcal infections.
EP. 2: Clinical and Economic Burdens Driving Novel Pneumococcal Vaccine Development
Key opinion leaders discuss factors leading to the development of novel pneumococcal vaccines.
EP. 3: Patient Populations At High Risk for Pneumococcal Disease
High-risk patient populations for pneumococcal pneumonia are discussed by Christina Madison, PharmD, FCCP, AAHIVP.
EP. 4: Differential Diagnosis: Pneumococcal Pneumonia Versus Other Etiologies
William Schaffner, MD, and Christina Madison, PharmD, FCCP, AAHIVP provide an overview of the identification and differential diagnosis of pneumococcal pneumonia.
EP. 5: Managing Pneumococcal Disease to Mitigate Community Infection
Mary Bridgeman, PharmD, BCPS, BCGP, FASCP, drives a discussion around preventative measures to limit the spread of pneumococcal infection.
EP. 6: Current Vaccines for Pneumococcal Infection
Dr. Bridgeman highlights approved pneumococcal vaccines and their indications.
EP. 7: Immunization Schedule for Adults Who Received An Earlier Pneumococcal Conjugate Vaccine
Secondary pneumococcal vaccine schedules are explored by Drs Schaffner, Bridgeman, and Madison.
EP. 8: Examining the Need for Novel Pneumococcal Vaccines
The panelists discuss the evolution of the pneumococcal vaccine landscape.
EP. 9: Barriers Inhibiting Optimal Pneumococcal Vaccination Rates
Medical experts discuss clinical, social, and economic obstacles limiting pneumococcal vaccination efforts.
EP. 10: Patient Engagement and Education for Pneumococcal Vaccines
The significance of engaging patients and providing key educational points regarding pneumococcal vaccines is highlighted.
EP. 11: Racial and Ethnic Disparities Impacting Vaccination Rates
Christina Madison, PharmD, FCCP, AAHIVP, discusses disparities in patient populations directly influencing limited access to appropriate treatment and preventative care.
EP. 12: Leveraging Multidisciplinary Teams to Maximize Pneumococcal Immunization Rates
Dr Schaffner underscores the significance of multidisciplinary teams in the effort to optimize vaccination rates for pneumococcal disease.
EP. 13: Medicare and Medicaid Responses to Pneumococcal Vaccines
Cost considerations for the rollout of new pneumococcal vaccines are discussed by a panel of medical experts.
2 Clarke Drive Cranbury, NJ 08512